Timing and impact of decisions to adjust disease-modifying antirheumatic drug therapy for rheumatoid arthritis patients with active disease.

about

Timing and impact of decisions to adjust disease-modifying antirheumatic drug therapy for rheumatoid arthritis patients with active disease.

Item

http://www.wikidata.org/entity/Q47262286

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Timing and impact of decisions ...... patients with active disease.

@en

Timing and impact of decisions ...... patients with active disease.

@nl

type

Item

label

Timing and impact of decisions ...... patients with active disease.

@en

Timing and impact of decisions ...... patients with active disease.

@nl

prefLabel

Timing and impact of decisions ...... patients with active disease.

@en

Timing and impact of decisions ...... patients with active disease.

@nl

P1476

Timing and Impact of Decisions ...... s Patients With Active Disease

@en

P2093

Chung-Chou H Chang

http://www.w3.org/2001/XMLSchema#string

Julie M Donohue

http://www.w3.org/2001/XMLSchema#string

Marc C Levesque

http://www.w3.org/2001/XMLSchema#string

Mark S Roberts

http://www.w3.org/2001/XMLSchema#string

P2860

2012 update of the 2008 American College of Rheumatology recommendations for the use of disease-modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid arthritis

EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 update

A note on competing risks in survival data analysis

Rheumatoid arthritis disease activity measures: American College of Rheumatology recommendations for use in clinical practice.

Understanding why rheumatoid arthritis patient treatment preferences differ by race.

High disease activity may not be sufficient to escalate care

Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases.

Characterising deviation from treat-to-target strategies for early rheumatoid arthritis: the first three years.

Prescribing practices in a US cohort of rheumatoid arthritis patients before and after publication of the American College of Rheumatology treatment recommendations.

The use and interpretation of competing risks regression models

P304

834-841

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/ACR.23418

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Kaleb Michaud

Yomei Shaw

P577

2018-04-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28941147

http://www.w3.org/2001/XMLSchema#string

P932

5862728

http://www.w3.org/2001/XMLSchema#string